These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 2315906)

  • 21. Diagnostic dilemmas resulting from the immunoreactive trypsinogen/DNA cystic fibrosis newborn screening algorithm.
    Parad RB; Comeau AM
    J Pediatr; 2005 Sep; 147(3 Suppl):S78-82. PubMed ID: 16202789
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Declining prevalence of cystic fibrosis since the introduction of newborn screening.
    Massie J; Curnow L; Gaffney L; Carlin J; Francis I
    Arch Dis Child; 2010 Jul; 95(7):531-3. PubMed ID: 20551198
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Overview of published evidence on outcomes with early diagnosis from large US observational studies.
    Rosenfeld M
    J Pediatr; 2005 Sep; 147(3 Suppl):S11-4. PubMed ID: 16202774
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Growth and long-term lung function in cystic fibrosis: a longitudinal study of patients diagnosed by neonatal screening.
    Assael BM; Casazza G; Iansa P; Volpi S; Milani S
    Pediatr Pulmonol; 2009 Mar; 44(3):209-15. PubMed ID: 19230003
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Does cystic fibrosis neonatal screening detect atypical CF forms? Extended genetic characterization and 4-year clinical follow-up.
    Narzi L; Ferraguti G; Stamato A; Narzi F; Valentini SB; Lelli A; Delaroche I; Lucarelli M; Strom R; Quattrucci S
    Clin Genet; 2007 Jul; 72(1):39-46. PubMed ID: 17594398
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neonatal screening for cystic fibrosis. Early diagnosis allows option of prenatal diagnosis in subsequent pregnancies.
    Lane B; Harris R; Harris H
    BMJ; 1998 Aug; 317(7155):411. PubMed ID: 9729095
    [No Abstract]   [Full Text] [Related]  

  • 27. Cystic fibrosis diagnosed after 2 months of age leads to worse outcomes and requires more therapy.
    Sims EJ; Clark A; McCormick J; Mehta G; Connett G; Mehta A;
    Pediatrics; 2007 Jan; 119(1):19-28. PubMed ID: 17200267
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Neonatal screening for mucoviscidosis using the BM-test-meconium].
    Grüttner R; Clemens P; Koepp P; Held KH; Plettner C; Stern M
    Monatsschr Kinderheilkd; 1985 Jan; 133(1):54-6. PubMed ID: 3883133
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preventing early, prolonged vitamin E deficiency: an opportunity for better cognitive outcomes via early diagnosis through neonatal screening.
    Koscik RL; Lai HJ; Laxova A; Zaremba KM; Kosorok MR; Douglas JA; Rock MJ; Splaingard ML; Farrell PM
    J Pediatr; 2005 Sep; 147(3 Suppl):S51-6. PubMed ID: 16202783
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Complications associated with symptomatic diagnosis in infants with cystic fibrosis.
    Accurso FJ; Sontag MK; Wagener JS
    J Pediatr; 2005 Sep; 147(3 Suppl):S37-41. PubMed ID: 16202780
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Survival and clinical outcome in patients with cystic fibrosis, with or without neonatal screening.
    Dankert-Roelse JE; te Meerman GJ; Martijn A; ten Kate LP; Knol K
    J Pediatr; 1989 Mar; 114(3):362-7. PubMed ID: 2921680
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cystic fibrosis newborn screening: impact of early screening results on parenting stress.
    Baroni MA; Anderson YE; Mischler E
    Pediatr Nurs; 1997; 23(2):143-51. PubMed ID: 9165929
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cystic fibrosis birth rates in Canada: a decreasing trend since the onset of genetic testing.
    Dupuis A; Hamilton D; Cole DE; Corey M
    J Pediatr; 2005 Sep; 147(3):312-5. PubMed ID: 16182667
    [TBL] [Abstract][Full Text] [Related]  

  • 34. New York State cystic fibrosis consortium: the first 2.5 years of experience with cystic fibrosis newborn screening in an ethnically diverse population.
    Giusti R; Badgwell A; Iglesias AD;
    Pediatrics; 2007 Feb; 119(2):e460-7. PubMed ID: 17272608
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A survey of newborn screening for cystic fibrosis in Europe.
    Southern KW; Munck A; Pollitt R; Travert G; Zanolla L; Dankert-Roelse J; Castellani C;
    J Cyst Fibros; 2007 Jan; 6(1):57-65. PubMed ID: 16870510
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Clinical heterogeneity at the diagnosis in a cystic fibrosis population].
    Lucidi V; Rosati P; Bella S; Papadatou B; Ferretti F; Orrù M; Diámanti A; Castro M
    Pediatr Med Chir; 1995; 17(1):57-9. PubMed ID: 7739929
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Implementing prenatal screening for cystic fibrosis in routine obstetric practice.
    Fries MH; Bashford M; Nunes M
    Am J Obstet Gynecol; 2005 Feb; 192(2):527-34. PubMed ID: 15695998
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Implementation of informed consent for a cystic fibrosis newborn screening program in France: low refusal rates for optional testing.
    Dhondt JL
    J Pediatr; 2005 Sep; 147(3 Suppl):S106-8. PubMed ID: 16202772
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Value of neonatal screening for cystic fibrosis. Evaluation of a neonatal screening program including 34,522 neonates (author's transl)].
    Cristol P; Des Georges M; Levy A; Sahuc P
    Sem Hop; 1982 Feb; 58(8):499-55. PubMed ID: 6278637
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The impact of cystic fibrosis on neonatal intestinal obstruction: the need for prenatal/neonatal screening.
    Casaccia G; Trucchi A; Nahom A; Aite L; Lucidi V; Giorlandino C; Bagolan P
    Pediatr Surg Int; 2003 Apr; 19(1-2):75-8. PubMed ID: 12721730
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.